164 related articles for article (PubMed ID: 15798964)
1. Contribution of impaired glucose tolerance in subjects with the metabolic syndrome: Baltimore Longitudinal Study of Aging.
Rodriguez A; Muller DC; Engelhardt M; Andres R
Metabolism; 2005 Apr; 54(4):542-7. PubMed ID: 15798964
[TBL] [Abstract][Full Text] [Related]
2. Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study.
Sicree RA; Zimmet PZ; Dunstan DW; Cameron AJ; Welborn TA; Shaw JE
Diabet Med; 2008 Mar; 25(3):296-302. PubMed ID: 18307457
[TBL] [Abstract][Full Text] [Related]
3. Predicting isolated postchallenge hyperglycaemia: a new approach; Tehran Lipid and Glucose Study (TLGS).
Hosseinpanah F; Rambod M; Reza Ghaffari HR; Azizi F
Diabet Med; 2006 Sep; 23(9):982-9. PubMed ID: 16922704
[TBL] [Abstract][Full Text] [Related]
4. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
Mula-Abed WA; Al-Naemi AH
Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
[TBL] [Abstract][Full Text] [Related]
5. The importance of diagnostic criteria in the association between the metabolic syndrome and cardiovascular disease in obese subjects.
Vidal J; Morínigo R; Codoceo VH; Casamitjana R; Pellitero S; Gomis R
Int J Obes (Lond); 2005 Jun; 29(6):668-74. PubMed ID: 15753955
[TBL] [Abstract][Full Text] [Related]
6. The likelihood of diabetes based on the proposed definitions for impaired fasting glucose.
Gao W; Dong Y; Nan H; Tuomilehto J; Qiao Q
Diabetes Res Clin Pract; 2008 Jan; 79(1):151-5. PubMed ID: 17825938
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and its components in men.
Adriansjah H; Adam JM
Acta Med Indones; 2005; 37(2):66-70. PubMed ID: 20066787
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of metabolic syndrome in an Indian urban population.
Gupta R; Deedwania PC; Gupta A; Rastogi S; Panwar RB; Kothari K
Int J Cardiol; 2004 Nov; 97(2):257-61. PubMed ID: 15458693
[TBL] [Abstract][Full Text] [Related]
9. [Impact of lowering the cut-point for impaired fasting glucose on the distribution of impaired glucose regulation subcategories in Chinese adult population].
Yang ZJ; Yang WY; Xiao JZ; Li GW; Wang Y
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1773-6. PubMed ID: 15631770
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome in Saudi Arabia.
Al-Nozha M; Al-Khadra A; Arafah MR; Al-Maatouq MA; Khalil MZ; Khan NB; Al-Mazrou YY; Al-Marzouki K; Al-Harthi SS; Abdullah M; Al-Shahid MS; Al-Mobeireek A; Nouh MS
Saudi Med J; 2005 Dec; 26(12):1918-25. PubMed ID: 16380773
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke.
Kernan WN; Viscoli CM; Inzucchi SE; Brass LM; Bravata DM; Shulman GI; McVeety JC
Arch Intern Med; 2005 Jan; 165(2):227-33. PubMed ID: 15668371
[TBL] [Abstract][Full Text] [Related]
12. Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women.
Otsuki M; Kasayama S; Morita S; Asanuma N; Saito H; Mukai M; Koga M
Menopause; 2007; 14(3 Pt 1):404-7. PubMed ID: 17213751
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the prevalence of depressive symptoms and metabolic syndrome. Results of the SOPKARD Project.
Gil K; Radziłłowicz P; Zdrojewski T; Pakalska-Korcala A; Chwojnicki K; Piwoński J; Ignaszewska-Wyrzykowska A; Załuga L; Mielczarek M; Landowski J; Wyrzykowski B
Kardiol Pol; 2006 May; 64(5):464-9. PubMed ID: 16752328
[TBL] [Abstract][Full Text] [Related]
14. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
Adam JM; Tarigan NP
Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
[TBL] [Abstract][Full Text] [Related]
15. Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose: more results from the Paris Prospective Study.
Balkau B; Forhan A; Eschwège E
Diabetologia; 2002 Sep; 45(9):1224-30. PubMed ID: 12242454
[TBL] [Abstract][Full Text] [Related]
16. Features of isolated post-challenge hyperglycaemia in Jamaican adults.
Boyne MS; Sargeant LA; Bennett FI; Cooper RS; Wilks RJ; Forrester TE
West Indian Med J; 2004 Jan; 53(1):7-11. PubMed ID: 15114886
[TBL] [Abstract][Full Text] [Related]
17. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome--the Chennai Urban Rural Epidemiology Study.
Gokulakrishnan K; Deepa R; Mohan V; Gross MD
Metabolism; 2006 Feb; 55(2):237-42. PubMed ID: 16423632
[TBL] [Abstract][Full Text] [Related]
18. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging.
Meigs JB; Muller DC; Nathan DM; Blake DR; Andres R;
Diabetes; 2003 Jun; 52(6):1475-84. PubMed ID: 12765960
[TBL] [Abstract][Full Text] [Related]
19. Fine-tuning of prediction of isolated impaired glucose tolerance: a quantitative clinical prediction model.
Rambod M; Hosseinpanah F; Ardakani EM; Padyab M; Azizi F
Diabetes Res Clin Pract; 2009 Jan; 83(1):61-8. PubMed ID: 19012984
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): prevalence and associated factors in the adult population of Telde, Gran Canaria.
Boronat M; Varillas VF; Saavedra P; Suárez V; Bosch E; Carrillo A; Nóvoa FJ
Diabet Med; 2006 Feb; 23(2):148-55. PubMed ID: 16433712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
